The company successfully completed inspection by Pharmaceuticals and Medical Devices Agency (PMDA) Japanese Authorities for the manufacturing facility-Unit II, located in Hyderabad – Telangana.
The inspection was done during the period July 25 – 27. The inspection was focussed on general GMP (Good Manufacturing Practice) inspection of the site. The inspection has been concluded with no critical/major observation.
At 02:52 PM; the stock was up 16% to Rs 84.35 on BSE, as compared to 0.95% rise in the S&P BSE Sensex. The trading volumes on the counter jumped multiple-fold with a combined 1.2 million shares changed hands on BSE and NSE so far.
To read the full story, Subscribe Now at just Rs 249 a month
Already a subscriber? Log in
Subscribe To BS Premium
₹249
Renews automatically
₹1699₹1999
Opt for auto renewal and save Rs. 300 Renews automatically
₹1999
What you get on BS Premium?
- Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
- Pick your 5 favourite companies, get a daily email with all news updates on them.
- Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
- Preferential invites to Business Standard events.
- Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
Need More Information - write to us at assist@bsmail.in